347 related articles for article (PubMed ID: 26039049)
61. Outcomes of low-risk ductal carcinoma in situ in Southeast Asian women treated with breast conservation therapy.
Wong FY; Wang F; Chen JJ; Tan CH; Tan PH
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):998-1003. PubMed ID: 24661651
[TBL] [Abstract][Full Text] [Related]
62. Disparities in reconstruction rates after mastectomy for ductal carcinoma in situ (DCIS): patterns of care and factors associated with the use of breast reconstruction for DCIS compared with invasive cancer.
Kruper L; Xu X; Henderson K; Bernstein L
Ann Surg Oncol; 2011 Oct; 18(11):3210-9. PubMed ID: 21863363
[TBL] [Abstract][Full Text] [Related]
63. Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer.
Agarwal S; Pappas L; Neumayer L; Kokeny K; Agarwal J
JAMA Surg; 2014 Mar; 149(3):267-74. PubMed ID: 24429935
[TBL] [Abstract][Full Text] [Related]
64. Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2018 Feb; 167(3):787-795. PubMed ID: 29119353
[TBL] [Abstract][Full Text] [Related]
65. Addressing overtreatment of screen detected DCIS; the LORIS trial.
Francis A; Thomas J; Fallowfield L; Wallis M; Bartlett JM; Brookes C; Roberts T; Pirrie S; Gaunt C; Young J; Billingham L; Dodwell D; Hanby A; Pinder SE; Evans A; Reed M; Jenkins V; Matthews L; Wilcox M; Fairbrother P; Bowden S; Rea D
Eur J Cancer; 2015 Nov; 51(16):2296-303. PubMed ID: 26296293
[TBL] [Abstract][Full Text] [Related]
66. Epidemiologic risk factors for in situ and invasive ductal breast cancer among regularly screened postmenopausal women by grade in the Cancer Prevention Study-II Nutrition Cohort.
Puvanesarajah S; Gapstur SM; Gansler T; Sherman ME; Patel AV; Gaudet MM
Cancer Causes Control; 2020 Jan; 31(1):95-103. PubMed ID: 31802322
[TBL] [Abstract][Full Text] [Related]
67. The clinical features and management of women with ductal carcinoma in situ with microinvasion: A retrospective Cohort study.
Li Y; Zhang S; Wei X; Zhang J
Int J Surg; 2015 Jul; 19():91-4. PubMed ID: 26013173
[TBL] [Abstract][Full Text] [Related]
68. Survival benefit of postoperative radiotherapy for ductal carcinoma in situ after breast-conserving surgery: a Korean population-based cohort study.
Kim BH; Ko BK; Bae JW; Nam S; Park MH; Jeong J; Lee HJ; Chang JH; Kim S; Hwang KT
Breast Cancer Res Treat; 2019 Nov; 178(1):105-113. PubMed ID: 31346856
[TBL] [Abstract][Full Text] [Related]
69. Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ.
Elshof LE; Schmidt MK; Rutgers EJT; van Leeuwen FE; Wesseling J; Schaapveld M
Ann Surg; 2018 May; 267(5):952-958. PubMed ID: 28375855
[TBL] [Abstract][Full Text] [Related]
70. The Role of Intraoperative Pathologic Assessment in the Surgical Management of Ductal Carcinoma In Situ.
Decker MR; Trentham-Dietz A; Loconte NK; Neuman HB; Smith MA; Punglia RS; Greenberg CC; Wilke LG
Ann Surg Oncol; 2016 Sep; 23(9):2788-94. PubMed ID: 27026436
[TBL] [Abstract][Full Text] [Related]
71. Variations in treatment for ductal carcinoma in situ in elderly women.
Gold HT; Dick AW
Med Care; 2004 Mar; 42(3):267-75. PubMed ID: 15076826
[TBL] [Abstract][Full Text] [Related]
72. Racial disparities in disease-specific mortality and surgical management of patients with ductal carcinoma in situ with microinvasion.
Chen JC; Handley D; Elsaid MI; Fisher JL; Owusu-Brackett N; Azap L; Bhattacharyya O; Pawlik TM; Carson WE; Obeng-Gyasi S
J Surg Oncol; 2024 Jun; 129(7):1179-1186. PubMed ID: 38643486
[TBL] [Abstract][Full Text] [Related]
73. Current approach and future perspective for ductal carcinoma in situ of the breast.
Kanbayashi C; Iwata H
Jpn J Clin Oncol; 2017 Aug; 47(8):671-677. PubMed ID: 28486668
[TBL] [Abstract][Full Text] [Related]
74. Digital mammography screening: association between detection rate and nuclear grade of ductal carcinoma in situ.
Weigel S; Heindel W; Heidinger O; Berkemeyer S; Hense HW
Radiology; 2014 Apr; 271(1):38-44. PubMed ID: 24475843
[TBL] [Abstract][Full Text] [Related]
75. Breast scintigraphy with breast-specific γ-camera in the detection of ductal carcinoma in situ: a correlation with mammography and histologic subtype.
Spanu A; Sanna D; Chessa F; Cottu P; Manca A; Madeddu G
J Nucl Med; 2012 Oct; 53(10):1528-33. PubMed ID: 22911882
[TBL] [Abstract][Full Text] [Related]
76. Causes of death and relative survival of older women after a breast cancer diagnosis.
Schonberg MA; Marcantonio ER; Ngo L; Li D; Silliman RA; McCarthy EP
J Clin Oncol; 2011 Apr; 29(12):1570-7. PubMed ID: 21402602
[TBL] [Abstract][Full Text] [Related]
77. Trends in cardiac mortality in women with ductal carcinoma in situ.
Haque W; Verma V; Haque A; Butler EB; Teh BS
Breast Cancer Res Treat; 2017 Jan; 161(2):345-351. PubMed ID: 27858317
[TBL] [Abstract][Full Text] [Related]
78. Risk of death from breast cancer after treatment for ductal carcinoma in situ.
Wadsten C; Garmo H; Fredriksson I; Sund M; Wärnberg F
Br J Surg; 2017 Oct; 104(11):1506-1513. PubMed ID: 28832961
[TBL] [Abstract][Full Text] [Related]
79. Breast implants following mastectomy in women with early-stage breast cancer: prevalence and impact on survival.
Le GM; O'Malley CD; Glaser SL; Lynch CF; Stanford JL; Keegan TH; West DW
Breast Cancer Res; 2005; 7(2):R184-93. PubMed ID: 15743498
[TBL] [Abstract][Full Text] [Related]
80. Clinical outcomes of patients with ductal carcinoma in situ in Hong Kong: 10-year territory-wide cancer registry study.
Co M; Ngan RKC; Mang OWK; Tam AHP; Wong KH; Kwong A
Hong Kong Med J; 2020 Dec; 26(6):486-491. PubMed ID: 33277445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
